Our most ambitious fundraising effort to date, the $600 million Campaign for Cedars-Sinai will propel groundbreaking research and patient care for decades to come. Donors will have the opportunity to invest in the most relevant biomedical research areas of our time, including five strategic initiatives: disease prevention and control; precision medicine and targeted therapies; aging and longevity; innovations in healthcare and technology; and education and training.
From the Dean
When I was a medical resident in the 1960s, hand hygiene was barely discussed as an imperative. We were taught to wash our hands before seeing patients, but we rarely saw this behavior modeled by senior physicians. Today, medical institutions Read On
Can a structure of steel and stone determine the course of medical discovery in the age of genomics and nanomedi- cine? That question is posed with the recent opening of Cedars-Sinai’s Advanced Health Sciences Pavilion. For answers, we need to Read On
I learned the word “insulin” when I was just 7 years old. That year, my young father was diagnosed with diabetes. At an age when most children are frightened of needles, my siblings and I grew accustomed to watching him Read On
As a newly qualified physician, I was excited and intrigued when President Richard Nixon signed the National Cancer Act of 1971. He called it “a national commitment for the conquest of cancer, to attempt to find a cure.” His words Read On
While we were busy assembling the “Ideas” issue of Discoveries magazine, we received word—along with the rest of the world—that Steve Jobs had passed away. Apple’s brilliant co-founder and CEO captured the imagination of inventors, businessmen, and consumers alike. Since Read On